University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Chemical and Biomolecular Engineering -- All
Faculty Papers

Chemical and Biomolecular Engineering,
Department of

2018

Scalable and physiologically relevant microenvironments for
human pluripotent stem cell expansion and differentiation
Qiang Li
University of Nebraska-Lincoln, qli18@unl.edu

Haishuang Lin
University of Nebraska - Lincoln, hlin9@unl.edu

Qian Du
University of Nebraska - Lincoln, qdu8@unl.edu

Kan Liu
University of Nebraska-Lincoln, kliu7@unl.edu

Ou Wang
University of Nebraska - Lincoln, owang@unl.edu

See next page for additional authors

Follow this and additional works at: https://digitalcommons.unl.edu/chemengall

Li, Qiang; Lin, Haishuang; Du, Qian; Liu, Kan; Wang, Ou; Evans, Catelyn; Christian, Hannah; Zhang, Chi; and
Lei, Yuguo, "Scalable and physiologically relevant microenvironments for human pluripotent stem cell
expansion and differentiation" (2018). Chemical and Biomolecular Engineering -- All Faculty Papers. 75.
https://digitalcommons.unl.edu/chemengall/75

This Article is brought to you for free and open access by the Chemical and Biomolecular Engineering, Department
of at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Chemical and
Biomolecular Engineering -- All Faculty Papers by an authorized administrator of DigitalCommons@University of
Nebraska - Lincoln.

Authors
Qiang Li, Haishuang Lin, Qian Du, Kan Liu, Ou Wang, Catelyn Evans, Hannah Christian, Chi Zhang, and
Yuguo Lei

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
chemengall/75

Biofabrication

PAPER • OPEN ACCESS

Scalable and physiologically relevant microenvironments for human
pluripotent stem cell expansion and differentiation
To cite this article: Qiang Li et al 2018 Biofabrication 10 025006

View the article online for updates and enhancements.

This content was downloaded from IP address 129.93.16.87 on 10/05/2018 at 22:37

Biofabrication 10 (2018) 025006

https://doi.org/10.1088/1758-5090/aaa6b5

PAPER

OPEN ACCESS

Scalable and physiologically relevant microenvironments for human
pluripotent stem cell expansion and differentiation

RECEIVED

29 August 2017
REVISED

15 December 2017

Qiang Li1,2, Haishuang Lin1, Qian Du3, Kan Liu3, Ou Wang1,2, Catelyn Evans4, Hannah Christian4,
Chi Zhang3 and Yuguo Lei1,2,5,6
1

ACCEPTED FOR PUBLICATION

10 January 2018
PUBLISHED

1 February 2018

Original content from this
work may be used under
the terms of the Creative
Commons Attribution 3.0
licence.

2
3
4
5

6

Department of Chemical and Biomolecular Engineering, University of Nebraska, Lincoln, Nebraska, United States of America
Biomedical Engineering Program, University of Nebraska, Lincoln, Nebraska, United States of America
School of Biological Science, University of Nebraska, Lincoln, Nebraska, United States of America
Department of Biological Systems Engineering, University of Nebraska, Lincoln, Nebraska, United States of America
Mary and Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska, United States of
America
Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

E-mail: ylei14@unl.edu
Keywords: human pluripotent stem cells, expansion and differentiation, 3D culture system

Any further distribution of
Supplementary material for this article is available online
this work must maintain
attribution to the
author(s) and the title of
the work, journal citation
and DOI.

Abstract
Human pluripotent stem cells (hPSCs) are required in large numbers for various biomedical
applications. However, the scalable and cost-effective culturing of high quality hPSCs and their
derivatives remains very challenging. Here, we report a novel and physiologically relevant 3D culture
system (called the AlgTube cell culture system) for hPSC expansion and differentiation. With this
system, cells are processed into and cultured in microscale alginate hydrogel tubes that are suspended
in the cell culture medium in a culture vessel. The hydrogel tubes protect cells from hydrodynamic
stresses in the culture vessel and limit the cell mass smaller than 400 μm in diameter to ensure efﬁcient
mass transport, creating cell-friendly microenvironments for growing cells. This system is simple,
scalable, highly efﬁcient, deﬁned and compatible with the current good manufacturing practices.
Under optimized culture conditions, the AlgTubes enabled long-term culture of hPSCs (>10 passages,
>50 days) with high cell viability, high growth rate (1000-fold expansion over 10 days per passage),
high purity (>95% Oct4+) and high yield (5.0×108 cells ml−1), all of which offer considerable
advantages compared to current approaches. Moreover, the AlgTubes enabled directed differentiation
of hPSCs into various tissue cells. This system can be readily scaled to support research from basic
biological study to clinical development and the future industry-scale production.

Introduction
Human pluripotent stem cells (hPSCs), including
human embryonic stem cells (hESCs) and induced
pluripotent stem cells (iPSCs), are attractive cell
sources for various biomedical applications including
cell therapies [1], tissue biofabrication [2–4], drug
screening and toxicity tests [5, 6]. These applications
require large numbers of high quality cells [7]. For
instance, it is estimated that ∼109 cardiomyocytes, 109
β cells, 1012 red blood cells, and 1011 platelets are
needed for treating one myocardial infarction or
diabetic patient, or one blood or platelet transfusion,
respectively [1]. Approximately 1010 cells are required
© 2018 IOP Publishing Ltd

for engineering a human-size heart or liver [5], or for
screening a library with one million compounds once
[6]. Considering the large patient population and the
large numbers of chemical libraries that can be
screened, massive numbers of cells are therefore
needed [7].
However, the scalable and cost-effective culturing
of high quality hPSCs and their derivatives, especially
for clinical applications, remains a challenge [1, 7, 8].
In vivo, majority of human cells including the hESCs
reside in 3D microenvironments that have plenty of
cell–cell and cell–ECM (extracellular matrix) interactions, sufﬁcient supply of nutrients, oxygen and
growth factors, and no or minimal hydrodynamic
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stresses [9–13]. The current hPSC culturing methods,
however, provide culturing conditions that are very
different from these physiological microenvironments, leading to low culture efﬁciency and difﬁculty
to culture cells at large scales. Two-dimensional (2D)
cell culturing (e.g. with cell culture ﬂasks) is the most
widely used method for culturing hPSCs. However, a
2D environment is very different from an in vivo
environment. Additionally, 2D culturing is labor-,
space- and reagent-consuming, and considered only
suitable for preparing small scale cells [1, 7, 8]. Threedimensional (3D) suspension culturing (e.g. with stirred-tank bioreactors), in which cells are suspended in
the culture medium, has been widely studied to scale
up the production and has achieved some attractive
results [1, 7, 8]. However, a critical problem with 3D
suspension culturing is the uncontrolled cell agglomeration (ﬁgures S1(A) and (B) are available online at
stacks.iop.org/BF/10/025006/mmedia) [1]. hPSCs
have strong cell–cell interactions that make them
aggregate [12, 13]. Suspended single hPSCs ﬁrst
associate to form small cell clusters (i.e., initial cell
clustering), which is important for the survival and
growth of dissociated hPSCs [12, 13]. These small cell
clusters grow as spherical aggregates (i.e., spheroids)
when cells divide. Spheroids, however, frequently fuse
to each other to form large cell agglomerates (i.e.,
agglomeration) (ﬁgures S1(A) and (B)). Agglomeration leads to inhomogeneity in cell aggregate size and
is detrimental to cell culture [1]. For instance, the
transport of nutrients, oxygen, and growth factors to,
and the metabolic waste from cells located at the center of large cell agglomerates (e.g., >400 μm diameter)
become insufﬁcient, leading to slow cell growth, apoptosis, and uncontrolled differentiation [1, 14]. While
agitating the culture can enhance mass transport and
reduce cell agglomeration, agitation also generates critical hydrodynamic stresses (e.g. shear stresses) that
negatively impacts cells [1, 15, 16]. With the uncontrolled cell aggregation and hydrodynamic stresses,
signiﬁcant cell death, low cell growth and low volumetric yield are common in 3D suspension culturing
[7]. For instance, we and others showed hPSCs typically expanded 4-fold in 4 days to yield around
2.0×106 cells ml−1 (table S1) [17–19]. These cells
occupy ∼0.4% of the bioreactor volume [20].
Furthermore, the hydrodynamic conditions (e.g.
the medium ﬂow direction, velocity, shear force and
chemical environment) generated by the agitation in
3D suspension culturing are very complicate [1, 7, 8,
15–19, 21]. They are spatially and temporally varied,
and sensitive to many factors including the bioreactor
design (e.g. impeller geometry, size and position, vessel geometry and size, positions of probes for pH,
temperature, oxygen), medium viscosity and agitation
rate [1, 21]. They are currently not well understood
and hard to control [1, 15, 16, 21]. Additionally, how
cells respond to these complicate hydrodynamic conditions is not well known and is hard to study
2

[1, 15, 16]. These complicate conditions and knowledge gap lead to culture inconsistency and difﬁculty in
scaling up, as shown by recent studies on producing
cardiomyocytes from hPSCs in stirred-tank bioreactors [22, 23]. For three batches (∼100 ml suspension cultures) using a hESC line, the ﬁnal yield ranged
from 40 million to 100 million cells, and ﬁnal cardiomyocyte purity ranged from 54% to 84%. Using the
same bioreactor and a different hPSC line, the ﬁnal
yield ranged from 89 million to 125 million cells, and
ﬁnal cardiomyocyte purity ranged from 28% to 88%
[22, 23]. When the culture volume was scaled from
∼100 ml to ∼1000 ml, the yield and differentiation
efﬁciency were altered. Re-optimizing bioreactor
design, agitation rate and culture protocol was
required [22, 23]. This indicates the challenge of further scaling up the culture volume (e.g. to hundreds
liters) since optimizing multiple factors in large culture volume is costly. To our best knowledge, the largest 3D suspension culture volume demonstrated to
date for hPSCs is less than 10 l [1, 24].
Researchers have tried to encapsulate and culture
hPSCs in various hydrogel scaffolds with the goal of
using scaffolds as physical barriers to isolate cells from
agglomeration and hydrodynamic stresses [7, 17,
25–29]. We recently found hPSCs could be effectively
cultured in a very soft and thermoreversible hydrogel
matrix (Mebiol® Gel) [7, 17, 29]. Within this hydrogel
matrix, single hPSCs clonally grew into uniform
spheroids (diameter ∼100–150 μm) (ﬁgures S1(C)
and (D)). The hydrogel scaffold enabled serial expansion of hPSCs with good cell viability, growth rate (e.g.
20-fold/5 days), yield (e.g. 2.0×107 cells ml−1) and
purity, all of which offered improvements over 3D
suspension cultures. However, this system has some
limitations that make it inappropriate for large-scale
cell production. First, it is not universally applicable.
For some hPSC lines and human cell types, the dissociated cells cannot survive and clonally grow in the
hydrogel. Though the exact reason is still unknown,
we speculate that the scaffold prevents the initial cell–
cell interactions that are important for cell’s survival
[7, 17, 29]. Second, the volumetric yield and expansion
per passage are moderate, probably due to the fact that
cells encapsulated in hydrogels have no free space for
expansion and they have to deform scaffolds to create
spaces for the new cells [7, 17, 29]. Third, the hydrogel
is mechanically fragile, making it hard to be processed
into formats (e.g., beads) suitable for large-scale cell
cultures. And lastly, the hydrogel remains stable for
about two weeks, which prohibits its use for long-term
cell culture, such as differentiating hPSCs into neurons, which requires more than one month. The
results of this study showed that eliminating the cell
agglomeration and hydrodynamic stresses could signiﬁcantly improve the culture efﬁciency, however, free
spaces that allow the initial cellular interactions and
subsequent cell expansion were also important to
achieve high culture outcomes.
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Figure 1. Overview of the AlgTube cell culture system. (A), (B) Design principles of AlgTubes. Cells are processed into and cultured in
microscale alginate hydrogel tubes that are suspended in the cell culture medium in a culture vessel. The hydrogel tubes protect cells
from hydrodynamic stresses (e.g. shear stresses) in the culture vessel and conﬁne the cell mass less than 400 μm (in radial diameter) to
ensure efﬁcient mass transport. They also create physiologically relevant microspaces for cells to interact with each other and expand.
Cell culture medium can efﬁciently diffuse through the alginate hydrogel shell. An illustration (A) and microscope picture (B) of an
AlgTube are shown. (C)–(E) Extruding AlgTubes. The setup for extruding AlgTubes consists of two syringe pumps, a custom-made
micro-extruder and a CaCl2 buffer. To make AlgTubes, a cell solution (e.g. single cells suspended in hyaluronic acid solution) and an
alginate solution is pumped into the central channel and side channel of the micro-extruder, respectively, to form coaxial core–shell
ﬂows that are extruded through the nozzle of the micro-extruder into the CaCl2 buffer. The shell alginate ﬂow is instantly crosslinked
by Ca2+ ions to form an alginate hydrogel tube. (F) Proposed cell growth mechanism in AlgTubes. After extruding the AlgTubes,
individual cells ﬁrst associate to form small cell clusters (i.e. the initial clustering phase). Subsequently, cells proliferate and the small
cell clusters expand to form ﬁbrous cell mass (i.e. the cell expansion phase). (G) This mechanism was conﬁrmed with experiment. Two
vials of H9-hESCs, stained with blue and green ﬂuorescent dyes, respectively, were mixed at 1:1 and cultured in AlgTubes. Single cells
(day 0), small cell clusters (day 1), and ﬁbrous cell mass (day 9) were seen. (H), (I) ROCK inhibitors (RIs) are required for the survival of
single H9-hESCs. Live/dead staining showed majority of cells went apoptosis after 24 h without RIs (−RI) (H). Cells survived and
grew well with RIs (+RI) (I). Scale bar: 200 μm.

We here report a novel technology that can overcome the limitations of current hPSC culturing methods and provide physiologically relevant cell culture
microenvironments. With this technology, hPSCs are
processed into and cultured in microscale alginate
hydrogel tubes (or AlgTubes) that are suspended in the
cell culture medium in a culture vessel (ﬁgures 1(A)
3

and (B)). The hydrogel tubes create cell-friendly
microspaces that allow cells to interact with each other
and expand. Meanwhile, they protect cells from
hydrodynamic stresses in the culture vessel and conﬁne the cell mass less than 400 μm (in radial diameter)
to ensure efﬁcient mass transport during the entire
culture (ﬁgures 1(A) and (B)). Additionally, this
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technology is simple, scalable, deﬁned and compatible
with the current good manufacturing practices that
make it commercially viable. We showed that, under
optimized culture conditions, the AlgTubes offered
paradigm-shifting improvements in cell viability,
growth, yield, culture consistency and scalability over
current hPSC culturing technologies.

Methods
Materials
Fib-iPSCs and MSC-iPSCs were obtained from
Human Embryonic Stem Cell Core, Harvard Medical
School. MSC-iPSCs and Fib-iPSCs were reprogrammed from mesenchymal stem cells and ﬁbroblasts, respectively, by George Q. Daley Lab
(Children’s Hospital Boston, MA) and have been well
characterized and described in the literature [56]. H9hESCs (Cat #: WA09) were purchased from WiCell
Research Institute. Authentication and test for the free
of mycoplasma were performed by WiCell Research
Institute. A cell bank was established after we received
the cells for each line. For experiments, each aliquot
from the cell bank was used for less than 10 additional
passages. For hPSCs, the cell growth kinetics and
expression of pluripotency markers (e.g. Oct4,
Nanog), karyotype, and differentiation capability were
tested to ensure these cells had no major genetic
mutation or loss of their differentiation capabilities. L
Wnt3A cells (ATCC® CRL-2647™) were acquired
from ATCC.
Reagents and their supplies: PNIPAAAm-PEG (cat
# MBG-PMW20-5005, Cosmobio USA); E8 medium
(cat # A1517001, life technologies); Accutase: (cat #
A1110501, life technologies); Y-27632 (cat # 12983038-2, Sigma); Matrigel (cat # 08-774-552, Corning);
Sodium Hyaluronate: (cat # HA 700K-5, Lifecore
Biomedical); Methylcellulose stock solution (cat #
HSC001, R&D system); Sodium alginate (cat # 19413321, 80–120cp, Wako Chemicals). Vybrant multicolor cell-labeling kit (cat # V22889, Molecular
Probes); DMEM (cat # SH30003.03, GE Healthcare);
FBS (cat # s11150, Atlanta biologicals); G418 (cat #
BP6731, Fisher); Luciferase report assay kit (cat #
K801-200, Biovision); Calcein AM viability dye (cat #
50-169-52, eBiosicence); Ethidium homodimer I (cat
# 40010, Biotium); DAPI (cat # D9542, Sigma).
RNeasy mini kit (cat # 74104 QIAGEN). Propidium
Iodide (cat # 195458, MP Biomedicals, LLC). Antibodies used in this study were summarized in table S2.
Culturing hPSCs in 3D PNIPAAm-PEG hydrogel
hPSCs cells were maintained in PNIPAAm-PEG
hydrogel before culturing in AlgTubes as described in
our previous publications [7]. Brieﬂy, single hPSCs
cells were mixed with 10% PNIPAAm-PEG solution at
4 °C and cast on a 12-well plate, then incubated at
37 °C for 15 min to form a stable hydrogel before
4

adding warm E8 medium plus 10 μM Y-27632 (Rock
inhibitor). To passage cells, 2 ml of ice cold PBS was
added to each well for 2 min to dissolve the hydrogel.
Spheroids were collected by centrifuging at 100 g for
3 min, treated with Accutase at 37 °C for 12 min and
dissociated into single cells with pipettes.
Processing AlgTubes
A custom-made micro-extruder was used to process
AlgTubes. A hyaluronic acid (HA) or methylcellulose
(MC) solution containing single cells and an alginate
solution was pumped into the central and side channel
of the home-made micro-extruder, respectively, and
extruded into a CaCl2 buffer (100 mM) to make
AlgTubes. Subsequently, the CaCl2 buffer was replaced
by cell culture medium.
Culturing hPSCs in the AlgTubes
For a typical cell culture, 20 μl of cell solution in
AlgTubes were suspended in 2 ml E8 medium in a
6-well plate and cultured in an incubator with 5%
CO2, 21% O2 at 37 °C. Medium was changed daily. To
passage cells, medium was removed and alginate
hydrogels were dissolved with 0.5 mM EDTA for
5 min. Cell mass was collected by centrifuging at 100 g
for 5 min, treated with Accutase at 37 °C for 12 min
and dissociated into single cells for following culture.
Culturing L-Wnt3A-cells in AlgTubes
For a typical cell culture, 20 μl of cell solution in
AlgTubes were suspended in 2 ml DMEM medium
plus 10% FBS in a 6-well plate and cultured in an
incubator with 5% CO2, 21% O2 at 37 °C. Medium
was changed daily and collected for quantifying
Wnt3A proteins. To quantify Wnt3A proteins, MDA468 cells (ATCC® HTB-132™) were stably transfected
with a luciferase reporter for the canonical Wnt
signaling (Addgene, # 24308). These MDA-468-TFP
cells were plated in a 96 well plate (5000 cells/well/
200 μl medium). 24 h later, 150 μl of fresh DMEM
plus 10% FBS and 50 μl of L-Wnt3A-cells conditioned
medium was added and incubated for another 18 h.
Medium was then removed and cells were washed with
PBS once before 200 μl of cell lysis buffer was added
and incubated for 10 min at room temperature. 50 μl
of cell lysates, 50 μl of substrate A and 50 μl of
substrate B from the luciferase assay kit were mixed
and the light signals were immediately read with a
luminometer. The quantity of Wnt3A protein was
calculated with a standard curve.
Culturing hPSCs in the AlgTubes with bioreactor
2 ml of cell solution in AlgTubes were suspended in a
home-made bioreactor. Cells were cultured in an
incubator with 5% CO2, 21% O2 at 37 °C for 10 days.
Medium was stored in a bellow bottle that was
periodically pressed to ﬂow the medium into, or
released to withdraw the medium from, the container.
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Staining, ﬂow cytometry and imaging
Cells cultured on 2D surfaces were ﬁxed with 4%
paraformaldehyde (PFA) at room temperature for
15 min, and permeabilized with 0.25% Triton X-100
for 15 min, and blocked with 5% donkey serum for
1 h. Cells were then incubated with primary antibodies
at 4 °C overnight. After extensive washing, secondary
antibodies and 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) were added and incubated for
another 1 h at room temperature. Cells were washed
with PBS three times before imaging with a Zeiss Axio
Observer Fluorescent Microscopy. The percentage of
Oct4+nuclei was quantiﬁed with Image J software. At
least 1000 nuclei were analyzed. To stain 3D ﬁbrous
cell mass, the cell mass was harvested and ﬁxed with
4% PFA at room temperature for 30 min, and then
incubated with PBS+0.25% Triton X-100+5%
goat serum+primary antibodies at 4 °C for 48 h.
After extensive washing, secondary antibodies in 2%
BSA were added and incubated at 4 °C for 24 h. Cells
were washed with PBS three times before imaging with
Nikon A1 Confocal Microscopy. For ﬂow cytometry,
single cells were ﬁxed with 4% paraformaldehyde
(PFA) at room temperature for 15 min, permeabilized
with 0.25% Triton X-100 for 15 min, and blocked with
5% donkey serum for 1 h. Cells were then incubated
with primary antibodies at 4 °C overnight. After
extensive washing, secondary antibodies were added
and incubated for another 2 h at room temperature.
Cells were washed with PBS two times before assessment using Cytek DxP 10 ﬂow cytometer (BD
Biosciences). Analysis was performed using FlowJo.
LIVE/DEAD® Cell Viability staining was used to assess
live and dead cells, according to the product manual.
EB differentiation
hPSCs released from the AlgTubes were suspended in
DMEM+20% FBS+10 μM β-mercaptoethanol in
a low adhesion plate for 6 days. The cell masses were
then transferred into plates coated with 0.1% gelatin
and cultured in the same medium for another 6 days,
followed by ﬁxation and staining as above.
Teratoma formation in vivo
All animal protocols were approved by the Institutional Animal Care and Use Committee of the
University of Nebraska–Lincoln. All experimental
procedures involving animals were performed in
accordance with the guidelines of the Institutional
Animal Care and Use Committee of the University of
Nebraska–Lincoln. 2×106 hPSCs were suspended in
25 μl of PBS plus 25 μl of Matrigel and injected
subcutaneously at the back of the neck of the NODSCID mice (female, age 7 weeks, Charles River
Laboratory). Tumors were harvested after 6–12 weeks.
The tumors were ﬁxed with 4% PFA for 48 h and
sequentially dehydrated with 70%, 95%, and 100%
ethanol, and deffated with xylene for 2 h before
5

embedding in parafﬁn. Then, 10 μm thick sections
were cut and stained with hematoxylin and eosin.
Karyotype
Karyotyping was performed by WiCell Research
Institute.
Mesodermal induction
hPSCs in AlgTubes were cultured in E8 medium for 7
days, and then in DMEM/F12 medium with 1% B27
minus insulin and 12 μM CHIR99021 for 24 h before
ﬁxation and staining.
Endodermal induction
hPSCs cells in AlgTubes were cultured in E8 medium
for 7 days; then in RPMI 1640 medium with 1%
GlutaMAX, 1% B27 minus insulin and 4 μM
CHIR99021 for 24 h; then in RPMI 1640 medium with
1% GlutaMAX and 1% B27 minus insulin for an
additional 24 h before ﬁxation and staining.
Cardiomyocyte differentiation
hPSCs cells in AlgTubes were cultured in E8 medium
for 7 days, then in DMEM/F12 with 1% B27-insulin
for 6 days, then DMEM/F12 with 1% B27 for 9 days.
The following small molecules were added during the
differentiation: 12 μM CHIR99021 for days 0–1; 5 μM
IWR1 for days 3–4. Cell mass were released on day 11
to a 6-well plate. Beating cardiomyocytes were ﬁlmed
on day 15.
Direct comparison of culturing hPSCs in 2D, static
3D and dynamic 3D suspension and the AlgTubes
For 2D culturing, 2×105 hPSCs were seeded in sixwell plate coated with Matrigel and cultured for 7 days.
For static 3D suspension, 2×105 cells ml−1 hPSCs
were suspended in low attachment 6-well plates and
cultured for 7 days. For dynamic 3D suspension,
2×105 cells ml−1 hPSCs were suspended in a spinner
ﬂasks (∼75 rpm) and cultured for 7 days. For AlgTubes, 1×106 cells ml−1 hPSCs were seeded and
cultured for 9 days. The culture medium was changed
daily and collected for measuring dead cells. Adenylate
kinases (AKs) are ubiquitous proteins present in all
eukaryotic and prokaryotic cells. They are rapidly
released into the culture medium upon damage of the
plasma membrane of cells. AKs in the cell culture
medium were quantiﬁed with the bioluminescence
cytotoxicity assay kit (cat # JM-K312-500, MBL
medical & biological laboratories) according to the
product instruction, and normalized with a standard
curve to calculate the dead cells in the culture medium
every 24 h. Samples were harvested and live cells were
counted with trypan blue. Single cells were ﬁxed with
70% ethanol for cell cycle analysis with propidium
iodide staining and ﬂow cytometry.
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RNA sequencing and data analysis
Total RNAs of day 3 hPSCs cultured in 2D, static 3D,
dynamic 3D and AlgTubes were prepared with RNeasy
mini kit (cat # 74104 QIAGEN) according to the
manufacturer’s instruction. Libraries were prepared
with TruSeq Stranded mRNA Library Prep Kit and
sequenced with Illumina NextSeq 500. 20 million
75 bp paired-end reads were generated for each
sample. The reads were trimmed to make sure the
average quality score was larger than 30 and the
minimum length was 40 bp. All trimmed short reads
were mapped to the human Genome (version hg19)
using TopHat, allowing up to two base mismatches
per read. Reads mapped to multiple locations were
discarded. Numbers of reads in genes were counted by
the HTSeq-count tool using corresponding human
gene annotations and the ‘union’ resolution mode.
For normalization and pair-wise comparisons, differentially expressed genes were identiﬁed by using
DEseq to analyze the numbers of reads aligned to
genes. The thresholds for differential expression were
set at fold-change >2 and adjusted P-values <0.001
for the null hypothesis.
Principle component analysis (PCA) analysis
PCA was implemented with R function prcomp and
the 3D PCA plot was produced with R package rgl. For
PCA analysis, genes with zero reads were discarded
and a natural log transformation was applied to the
number of reads for each gene. The proportion of total
variance accounted for by the ﬁrst three PCs was
64.46% (PC1 29.75%, PC2 18.06%, PC3 16.64%),
which suggested that those three PCs are sufﬁcient to
describe the major changing pattern of all samples.
Heatmap for gene expression. For each pathway, the
expression values of genes in the given pathway were
extracted and, to further stabilize the variance, a
natural log transformation was applied to normalized
read numbers for genes. The heatmap of expression
proﬁles for genes in a given pathway was plotted with
R package heatmap. In the heatmap, red indicates high
expression while green represents low expression.
Statistical analysis
The data are presented as the mean±S.D.. We used
an unpaired t-test to compare two groups and oneway ANOVA to compare more than two groups.
P<0.05 was considered statistically signiﬁcant.
Homogeneity of variances among groups were conﬁrmed using Bartlett’s test. Conformity to normal
distribution was conﬁrmed using the Kolmogorov–
Smirnov test. For in vitro experiments, a sample size of
3 or 5 was selected so that at a signiﬁcance level of 0.05
there at is least a 90% chance of detecting a two
standard deviation difference in cell numbers between
the groups.
6

Data availability
The ﬁnal processed data and raw fastq ﬁles were
submitted to Gene Expression Omnibus (GEO) with
the accession number GSE99776. All other data
supporting the ﬁndings of this study are available
within the paper and its Supplementary Information.

Results
A micro-extruder was designed and made for processing AlgTubes (ﬁgure 1). To make AlgTubes, a cell
solution and an alginate solution is pumped into the
central channel and side channel of the microextruder, respectively, to form coaxial core–shell ﬂows
that are extruded into a CaCl2 buffer. The shell alginate
ﬂow is instantly crosslinked by Ca2+ ions to form an
alginate hydrogel tube (ﬁgures 1(C)–(E)). Subsequently, the CaCl2 buffer is replaced by the cell culture
medium and cells are grown in the tubes. The microextruder can have multiple nozzles for simultaneously
processing multiple AlgTubes to make large-scale
AlgTubes (ﬁgure S2, and supplementary video 1). It
was found that the cell solution and alginate solution
should have close viscosity to process defect-free
AlgTubes. Both hyaluronic acid (HA) and methylcellulose (MC) solutions could be used to suspend cells
for this purpose. Similar to 3D suspension culturing
(ﬁgures S1(A) and (B)), single hPSCs in AlgTubes
quickly (e.g. within 24 h) associated to form small cell
clusters that subsequently grew and ﬁlled the tubes
(ﬁgures 1(F) and (G)). We termed these two phases as
the initial clustering phase and subsequent cell expansion phase, respectively. In 2D and 3D suspension
culturing of hPSCs, ROCK inhibitors (e.g. Y-27632)
are added to the culture medium for the ﬁrst 24 h after
passaging to inhibit the dissociation-induced cell
death [30]. We found ROCK inhibitors (Y-27632)
were also required for the survival and growth of the
single hPSCs in AlgTubes. Without ROCK inhibitors,
majority of cells died within 24 h (ﬁgures 1(H) and (I)).
To passage cells, the AlgTubes could be dissolved with
the cell-compatible ethylenediaminetetraacetic acid
(EDTA) solution (0.5 mM, 5 min at room temperature) to release the micro cell mass, which could be
further treated with Accutase (10 min at 37 °C) and
dissociated into single cells for the following passage.
We found AlgTubes made with a wide range of
alginate concentrations, tube diameters and hydrogel
shell thicknesses all supported efﬁcient culturing of
hPSCs (ﬁgures S3–S5). For instance, hPSCs grew efﬁciently and similarly in AlgTubes made with 1.0%,
1.5% and 2.0% alginate solutions (ﬁgure S3). When
seeded at 1.0×107 cells ml−1, cells expanded ∼14-,
23- and 50-fold to yield ∼1.4×, 2.3×and
5.0×108 cells ml−1 on day 5, 7 and 9 of the culturing
with above 94% cells expressed the pluripotency marker Oct4 at all three alginate concentrations. The AlgTube’s outer diameter is roughly equal to the inner

Biofabrication 10 (2018) 025006

Q Li et al

diameter of the nozzle of the micro-extruder and can
be controlled through adjusting the nozzle’s diameter
(ﬁgure S2). At a given AlgTube outer diameter, the
hydrogel shell thickness could be controlled by varying
the ratio of the cell solution ﬂow rate and alginate solution ﬂow rate and predicted by using the equation
described in ﬁgure S4(A). When seeded at
1.0×107 cells ml−1 and cultured in AlgTubes (with
∼400 μm diameter) with 30, 40, and 70 μm shells or
AlgTubes (with 30–50 μm shells) with diameter of
400 μm, 250 μm and 120 μm for 9 days, hPSCs all
expanded
around
50-fold
to
yield
∼5.0×108 cells ml−1 with above 90% cells retained
the pluripotency marker Oct4 (ﬁgures S4 and S5).
Since both HAs and MCs could be used to suspend
cells, we studied whether they differentially inﬂuenced
cell culture. Our research showed HAs and MCs resulted in similar cell viability, expansion and pluripotency (ﬁgure S6). The capability to support
consistent hPSC culturing under a wide range of AlgTube conditions gives users large ﬂexibility in processing the tubes.
AlgTubes supported efﬁcient hPSC culturing with
a wide range of seeding densities (ﬁgures 2 and S7).
When seeded at 1.0×, 2.0×, 5.0×, and
10.0×106 cells ml−1, hPSCs expanded 499-, 247-,
104- and 51-fold by day 9, respectively, yielding
around 5.0×108 cells ml−1 (ﬁgure 2). For all conditions, cells grew through the initial clustering phase
and the subsequent cell expansion phase. At 24 h after
processing the AlgTubes, the cell cluster size was larger
for higher seeding density but the numbers of cell clusters per volume were similar for different seeding densities (ﬁgure 2(A)). These results showed hPSCs grew
faster at lower seeding density (ﬁgures 2(B) and (C)).
However, the seeding density did not inﬂuence pluripotency. >95% cells expressed the pluripotency marker Oct4 for all seeding densities (ﬁgures 2(D) and
(E)). It is extremely exciting that hPSCs seeded at
ultralow densities could grow as well without sacriﬁcing cell viability and pluripotency (ﬁgure S7). When
seeded at 1.0×, 3.0×and 5.0×105 cells ml−1,
hPSCs expanded 4200-, 1700- and 1000-fold to yield
∼4.2×, 5.1×, and 5.0×108 cells ml−1 by days 14, 12
and 10, respectively.
After performing these optimizations, the AlgTubes were evaluated for culturing multiple hPSC
lines for long-term (e.g. 10 passages, ﬁgures 3, S8 and
S9). All hPSCs grew well in AlgTubes, and cell morphology, viability, growth rate, and pluripotency among
multiple hPSC lines were similar. In the 10-passage
culture, when seeded at 1.0×107 cells ml−1, hPSCs
consistently expanded ∼15-fold/passage/5 days and
>95% of cells expressed the pluripotency marker Oct4
(ﬁgures 3(A) and (B)). The long-term culture did not
alter cell phenotype as shown by the similar cell
morphology, viability, growth kinetics and pluripotency of hPSCs at passage 1 and 10 (ﬁgures 3, S8
and S9). When seeded at 1.0×107 cells ml−1, hPSCs
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expanded ∼50-fold to yield 5.0×108 cells ml−1 on
day 9 at both passage 1 and 10. In vitro embryoid body
(EB) differentiation and in vivo teratoma formation
conﬁrmed their pluripotency after the long-term culture. All hPSCs were successfully differentiated into
endodermal, mesodermal and ectodermal cells in the
EB assay (ﬁgures 4(A), S10(A) and (B)). All hPSCs
formed teratomas containing the three germ layer tissues in immune-deﬁcient mice in the teratoma assay
(ﬁgures 4(B), S10(C) and (D)). In addition, after longterm culture, all hPSCs retained normal karyotypes
(ﬁgures 4(C), S10(E) and (F)). These results show that
AlgTubes can support long-term culturing of hPSCs.
After expansion and further culturing in a mesodermal [31, 32] or endodermal [33] or cardiomyocyte
[31, 32] differentiation medium, hPSCs in the AlgTubes could be differentiated to corresponding mesodermal or endodermal cells or cardiomyocytes at high
efﬁciency, indicating the AlgTubes support hPSC differentiation (ﬁgures 4(D)–(F), and supplementary
video 2). Additionally, cells other than hPSCs can be
cultured in the AlgTubes. For instance, murine L cells
engineered to express Wnt3A proteins were efﬁciently
cultured without notable cell death [34], yielding
around 6.0×108 cells ml−1 (ﬁgure S11). Wnt3A proteins were consistently expressed during a 16 day culture. These results demonstrate AlgTube’ potential as
a generally applicable culture system.
A prototype bioreactor was built to show AlgTubes’ scalability (ﬁgure 5). Two milliliters of AlgTubes with hPSCs were processed and contained in a
bioreactor. The cell culture medium was stored in a
plastic bellow bottle that could be pressed to ﬂow the
medium into the bioreactor or released to withdraw
the medium from the bioreactor, respectively
(ﬁgure 5(A)). The pressing and releasing speed, as well
as the duration of the interval between the pressing
and releasing can be programmed and controlled by
the controller (ﬁgure 5(B)). Since AlgTubes have similar density with the cell culture medium, they were
uniformly suspended and dispersed in the medium
when the medium was pumped into the bioreactor.
They became collected and contact with each other
when the medium was withdrawn from the bioreactor. This alternating dispersion and collection is
designed to enhance the medium mixing. Within the
bioreactor, hPSCs grew well and yielded
∼5.0×108 cell ml−1 by day 10 (ﬁgures 5(C) and (D)).
>95% of cells expressed the pluripotency markers
(ﬁgures 5(E) and (F)). This prototype bioreactor could
be further scaled up in the future.
To assess the superiority of the AlgTubes over current hPSC culturing technologies, we directly compared culturing hPSCs in 2D, 3D suspension without
agitation (static 3D), 3D suspension with agitation
(dynamic 3D) and the AlgTubes (ﬁgure 6). Cells were
cultured for 9 days in AlgTubes to allow cells to ﬁll the
tubes. Cells were cultured for 7 days in 2D, static 3D
and dynamic 3D culturing since the cell numbers had
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Figure 2. The growth kinetics of H9-hESCs seeded at various seeding densities in AlgTubes. H9-hESCs were seeded at 1×, 2×, 5× or
10×106 cells ml−1 in AlgTubes and cultured for 9 days. (A) Phase images of cells on day 0, 1, 5 and 9 in AlgTubes. After 24 h, single
cells formed small clusters. The cell clusters were bigger at higher seeding density, but the number of clusters were similar (insert, day
1). Clusters grew into spheroids (day 5) and then ﬁbrous cell mass (day 9). (B) The expansion fold on day 5, 7 and 9 showed hPSCs grew
faster at lower seeding density, (C) while the ﬁnal volumetric yields on day 9 were very close. (D) Immunostaining showed ∼95% cells
expressed the pluripotency marker Oct4 after the 9 day culture. H9-hESCs were released from AlgTubes on day 9 and plated on a
Matrigel-coated plate overnight before ﬁxing and staining. (E) % of Oct4+cells were quantiﬁed with Image J Data are presented as
mean±SD of three independent replicates (n=3). Scale bar: (A) 400 μm; (D) 50 μm.
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Figure 3. AlgTubes supported long-term culturing of hPSCs. H9-hESCs, Fib-iPSCs and MSC-iPSCs were cultured in the AlgTubes for
10 passages. Fib-iPSCs and MSC-iPSCs are iPSCs made from human ﬁbroblasts and mesenchymal stem cells, respectively. (A) When
seeded at 1.0×107 cells ml−1, all three hPSCs consistently expanded ∼15-fold per passage per 5 days and (B) >95% of the cells
expressed Oct4 during the 10-passage culturing. Data are presented as mean±SD of three independent replicates (n=3). (C)–(H)
The growth kinetics of hPSCs at Passage 10. (C) Phase images of day 0, 3 and 5 H9-hESCs and (D) live/dead staining of day 7 H9hESCs in AlgTubes. (E), (F) Seeded at 1.0×107 cells ml−1, all three hPSCs expanded ∼15-, 24-, 53-fold to yield ∼150×, 240×,
530×106 cells ml−1 on day 5, 7 and 9, respectively. Data are presented as mean±SD of ﬁve independent replicates (n=5). (G)
Confocal microscope images and (H) ﬂow cytometry analysis showed majority cells on day 9 at passage 10 expressed pluripotency
markers: Nanog, Oct4, SSEA-4 and alkaline phosphatase (ALP). Scale bar: (C), (D) 400 μm; (G) 100 μm.

no further increase after 5 days in these cultures. Medium was changed daily. Live cells in the cultures were
counted daily. Cells died in each day were quantiﬁed
through measuring the adenylate kinases (AKs) in the
9

exhausted cell culture medium. AKs, which are ubiquitous proteins presented in cells, are rapidly released
into the culture medium upon damage of the plasma
membrane. The ratio of dead cells over the dead cells
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Figure 4. hPSCs retained pluripotency after long-term culturing in AlgTubes. After culturing in AlgTubes for 10 passages, H9-hESCs
could be differentiated into the Nestin+ectodermal, α-SMA+mesodermal and FOXA2+endodermal cells in the EB assay (A);
form teratomas containing the three germ layer tissues in teratoma assay (B); and had normal karyotype (C). By further culturing in a
mesodermal or endodermal or cardiomyocyte differentiation medium, H9-hESCs in AlgTubes could be differentiated into the
corresponding brachyury+mesodermal cells (D) or FOXA2+endodermal cells (E) or cTNT+cardiomyocytes (F). Fib-iPSCs and
MSC-iPSCs showed similar results (supplementary ﬁgure 10). Scale bar: (A), (B) 50 μm; (D)–(F) 100 μm.

plus the live cells was calculated (e.g. the % dead cells)
and used to assess the cell viability each day. Cell proliferation was also evaluated through quantifying the
percentage of cells in S and G2/M phases. Seeded at
2.0×105 cells ml−1, hPSCs expanded only 5-fold to
yield a maximum of ∼1.0×106 cells ml−1 in static 3D
culturing. At the same seeding density, hPSCs expanded ∼9-fold to yield a maximum of
∼1.8×106 cells ml−1 in dynamic 3D culturing. In
10

2D, cells could expand ∼51-fold to generate
∼1.0×107 cells per well of the 6-well plate. In AlgTubes, hPSCs expanded ∼500-fold to yield
∼5.0×108 cells ml−1 (ﬁgures 6(A) and (B)). Large
cell death was observed in static 3D, dynamic 3D and
2D culturing, especially after day 3 or when the cell
density reached ∼1.0×106 cells ml−1 (ﬁgures 6(D)
and (E)). In static 3D culturing, the % of dead cells
reached ∼43%, 53%, 59% and 62% on day 4, 5, 6 and
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Figure 5. An AlgTube-based prototype bioreactor. (A) AlgTubes with cells were suspended in a bioreactor. Medium was stored in a
plastic bellow bottle that could be pressed to ﬂow the medium into, or released to withdraw the medium from the bioreactor. (B)
Images of the mechanic stage for pressing and releasing the bellow bottle; the controller that can be programmed for the pressing and
releasing speed, as well as the duration of the interval between the pressing and releasing; and the bioreactor and bellow bottle. (C)
Image of the white ﬁbrous cell mass in the bioreactor on day 10. (D) ∼1.0×109 H9-hESCs were produced with 2.0 ml AlgTubes on
day 10. (E) Confocal microscope images and (F) ﬂow cytometry analysis showed majority the cells on day 10 expressed pluripotency
markers: Nanog, Oct4, SSEA-4 and alkaline phosphatase (ALP). Scale bar: (C) 1 cm; (E) 100 μm.

7, respectively. In dynamic 3D culturing, the % of dead
cells reached ∼28%, 29%, 35% and 40% on day 4, 5, 6
and 7, respectively. In AlgTubes, cell death was low
and the % of dead cells was <10% during the entire
9 day culture. Cell cycle analysis showed static 3D,
dynamic 3D and 2D culturing did not decrease the %
of cells in proliferation (ﬁgure 6(C)). To study whether
the global gene expression are different, mRNAs of the
day 3 cells from the 4 culturing methods were
sequenced. On day 3, cell death was not signiﬁcant and
majority of cells were proliferating in the 4 cultures
(ﬁgures 6(C)–(E)). Hierarchical clustering analysis
showed the gene expression proﬁles were very similar
between the 4 cultures (ﬁgures 6(F) and S12). These
results show that large cell death in 3D suspension culturing leads to low culture efﬁciency, and the AlgTubes improve the culture outcome through reducing
the cell death without signiﬁcantly altering the global
gene expression and cell phenotype.
We also directly compared encapsulating and culturing hPSCs in solid agarose, HA, and alginate hydrogels with suspending and culturing hPSCs in AlgTubes
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(ﬁgure S13). When seeded at 1×106 cells ml−1, little
cell expansions were observed in HA and agarose
hydrogels. Small numbers of spheroids were formed
and hPSCs expanded ∼3.5-fold in solid alginate
hydrogel ﬁbers. In AlgTubes, hPSCs expanded ∼500fold to yield ∼5.0×108 cells ml−1. These results show
the importance of the free microspaces for achieving
high cell expansion and yield.

Discussion
Based on the results of culturing hPSCs in 2D, 3D
suspension and hydrogels [7, 17, 25–29], we proposed
that 3D culture microenvironments having free space
for the initial cell–cell interactions and subsequent cell
growth, but no cell agglomeration and hydrodynamic
stresses could signiﬁcantly improve the culture efﬁciency. The AlgTubes are designed to provide these
physiologically
relevant
microenvironments
(ﬁgures 1(A) and (B)). First, cells in AlgTubes are
protected from hydrodynamic stresses/conditions by
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Figure 6. A direct comparison of culturing H9-hESCs in 2D, 3D suspension without agitation (static 3D), 3D suspension with
agitation (dynamic 3D) and AlgTubes. Cells were cultured for 7 days in 2D, static 3D and dynamic 3D culturing, and 9 days in
AlgTubes. (A) Expansion fold, (B) live cell density, (C) percentage of cells in S+G2/M phases, and (D) the ratio of dead cells over
(dead cells+live cells) or % dead cells in the cultures were quantiﬁed. (E) % dead cells was also plotted versus live cell densities. Data
are presented as mean±SD of 3 (n=3 for (A)–(C)) or 5 (n=5 for (D), (E)) replicates. Seeded at 2.0×105 cells ml−1, H9-hESCs
expanded ∼5- or 9-fold to yield a maximum of ∼1.0 or 1.8×106 cells ml−1 in static or dynamic 3D suspension, respectively. Large
cell death was detected. Starting on day 4 or at 1.0×106 cells ml−1 live cell density, the % dead cells reached 40% to 60% for static 3D
suspension and 20%–40% for dynamic 3D suspension. Starting on day 4, cell death became signiﬁcant in 2D culturing. In AlgTubes,
cells grew to ∼5×108 cells ml−1 with low cell death. The % dead cells was <10% during the entire culture in AlgTubes. The AlgTubes
did not enhance cells’ proliferation. (F) mRNAs of day 3 cells (3 biological replicates for each culture method) were sequenced.
Hierarchical clustering analysis of transcriptomes showed cells from the 4 culture methods had similar gene expression proﬁles. Note
for 2D culturing, the unit for cell density in (B), (E) is cells/well (of 6-well plate).

the hydrogel shells. This reduces the hydrodynamicconditions-induced negative effects [1, 15, 16, 21–23].
Second, cell masses in AlgTubes are controlled to be
less than 400 μm to ensure efﬁcient mass transport
during the entire culture. Additionally, the cell masses
are monodisperse (in radial diameter), which can
improve the homogeneity of hPSC expansion and
differentiation. Other methods, such as culturing cells
with AggreWell™, can precisely control cell aggregate
12

size, however, are not scalable. Third, unlike encapsulating and culturing cells in hydrogels (ﬁgure S13), the
AlgTubes provides free space for hPSC expansion and
does not hinder the initial cellular interaction, leading
to high volumetric yield and general applicability.
The use of alginates makes this new technology
scalable, cost-effective and GMP-compatible. Alginates are affordable; available in large quantity; nontoxic to cells; have been used in clinics; and can be
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instantly crosslinked with Ca2+ ions to process largescale AlgTubes with the scalable extrusion technology
(ﬁgure S2) [35]. The resulting AlgTubes are mechanically and chemically stable for months and suitable for
large-scale and long-term cell cultures; can be dissolved easily with cell-compatible EDTA solution to
release the product; and are transparent to allow
observation of cell growth [36].
The conceptual and technical innovations of AlgTubes lead to high culture efﬁciency. We demonstrated long-term culturing (>10 passages) of multiple
hPSC lines without uncontrolled differentiation and
chromosomal abnormalities (ﬁgures 3, S8 and S9).
Cultures between batches and cell lines were very consistent (ﬁgure 3(A)). hPSCs in AlgTubes had high viability, growth rate (1000-fold/10 days/passage in
general) and yield (∼5×108 cells ml−1 microspace).
The expansion per passage (e.g. up to 4200-fold/passage was achieved in ﬁgure S7) and volumetric yield
are much higher than current 3D suspension culturing
(table S1) [7, 8, 17, 37, 38]. For comparison, in 3D suspension culturing, we typically achieve 4-fold expansion per 4 days to yield around 2.0×106 cells ml−1.
As discussed later, the high yield and high expansion
fold have high impact on large-scale cell production
since they signiﬁcantly reduce the culture volume and
time, numbers of passaging operations, and the production cost. hPSCs could be efﬁciently differentiated
into various tissues cells (ﬁgure 4 and supplementary
video 2). In addition, AlgTubes-based scalable bioreactors could be readily built (ﬁgure 5). Our comparative study showed the AlgTubes did not signiﬁcantly
alter hPSCs’ gene expression proﬁles, but signiﬁcantly
reduced cell death, resulting in high cell expansion and
yield (ﬁgures 6 and S12).
It should be noted that pluripotent stem cells have
been cultured in hollow ﬁbers made from dry polymer
membranes [39–41]. However, their performance
offers no advancements over stirred-tank bioreactors.
In addition, harvesting cells from these ﬁbers were
very challenging. For instance, it required treating the
cells with trypsin for 30–60 min. Moreover, cells could
not be observed with microscopy and sampling was
hard during the culture. Solid hydrogel ﬁbers (e.g. not
hollow) have been studied for processing tissues
[42–44]. However, the AlgTubes are hollow and conceptually and technically different from these systems.
The AlgTubes will be of broad interest to individual laboratories, institutions, and biotechnology
companies working on regenerative medicine and
cancer therapies. First, AlgTubes provide laboratories
an easy-to-use tool for studying biology in 3D, which
can better replicate the in vivo biology than 2D cultures [45]. For instance, AlgTubes may be used to culture organoids [46, 47], study cellular assembly into
tissues [48] and reprogram cells [49], etc. Second, the
AlgTubes can greatly beneﬁt translational research.
Using hPSC-derived cardiomyocytes for treating
myocardial infarction as an example [50], 2D
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culturing was ﬁrst used for developing the differentiation protocol and the initial demonstration of efﬁcacy
and safety in rodents [51]. Subsequently, large effort
was spent to develop 3D suspension culturing for preparing sufﬁcient cardiomyocytes for tests on large animals [52, 53]. If successful, substantial amounts of
effort will be required to develop a new and large bioprocess for making sufﬁcient cells for clinical trials and
eventually clinics [50]. Since cell’s phenotype, safety
and efﬁcacy are bioprocess-related, extensive and
expensive in vitro and in vivo characterization of cell
phenotype, safety, and efﬁcacy are required after each
change of the culture method [54]. These efforts make
developing cellular therapeutics slow and expensive.
AlgTubes is scalable and can be used for culturing cells
for all these development stages. For instance, ∼200 μl
AlgTubes can be used for developing the differentiation protocol. ∼2 ml AlgTubes are sufﬁcient to produce ∼109 cells for preclinical small animal studies.
∼200 ml AlgTubes can yield ∼1011 cells for tests on
large animals and clinical trials. The AlgTubes can save
signiﬁcant time and investment for developing cellular
therapeutics. Third, the AlgTubes are very attractive
for industry-scale cell production. A simple comparative calculation of producing ∼1.5×1014 hPSCs
(from ∼108 hPSC seeds) with stirred-tank bioreactors
and AlgTubes shows the signiﬁcant impact of AlgTubes’ high cell expansion per passage and volumetric
yield (ﬁgure S14). For the calculation, we assumed
4-fold expansion per 4 days per passage for stirredtank bioreactors and 1000-fold expansion per 10 days
per passage for AlgTubes as well as a seeding density of
5×105 cells ml−1 and a passaging efﬁciency (i.e., %
of cells remaining viable after one passaging) of 80%
for both. These assumptions are based on data from
my lab and others (table S1) [7, 17, 24, 55]. The production requires ∼104, 811 liters of total culture
volume, 11 passaging operations, and 48 days with
stirred-tank bioreactors, which is technically and economically challenging (ﬁgures S14(A) and (C)). As
mentioned, building large stirred-tank bioreactors will
be very challenging. Passaging is highly unwanted for
large-scale cell production since it requires large
amounts of time, labor, and reagent; increases the risk
of contamination and culture failure; loses large numbers of cells; and causes difﬁculties during automation.
The production can be done with 320 l of AlgTubes in
20 days and 1 passaging (ﬁgures S14(B) and (C)). The
reductions in culture volume, time, and passaging not
only make the production technically feasible, but also
lead to enormous cuts in labor, reagents, equipment,
cGMP facility size, and overall production cost.
In summary, the AlgTube technology combines
physiologically relevant culture microenvironments,
high performance, high scalability, cGMP compliance
and commercial viability, and has potential to address
the hPSC manufacturing challenge. Advances in biology have developed protocols for efﬁciently differentiating hPSCs into many human cell types [7, 31].

Biofabrication 10 (2018) 025006

Q Li et al

Future research can explore integrating these protocols into AlgTubes to produce various human cell
types. It will be valuable to systematically study culturing other cell types, such as human adult stem cells and
T cells in AlgTubes.
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